Is Gestational trophoblastic disease hereditary?

Gestational trophoblastic disease (GTD) is generally not considered a hereditary condition passed down through families, but rather a group of pregnancy-related disorders arising from abnormal fertilization. While most cases occur as sporadic, de novo events, a rare familial form exists that is linked to specific genetic mutations, making genetic counseling essential for those with a history of recurrent molar pregnancies.

Is Gestational trophoblastic disease hereditary?

In the vast majority of cases, Gestational trophoblastic disease is not hereditary. It is important to distinguish between "genetic" and "hereditary." A disease is genetic if it involves the DNA within the cells, but it is only hereditary if it is passed from parent to child through the germline (sperm or egg). Most instances of Gestational trophoblastic disease arise from errors during the fertilization process—specifically, chromosomal imbalances that occur when an egg is fertilized by one or two sperm. Because these errors occur at conception, they are typically de novo, or spontaneous, and not inherited from the parents' own genetic makeup.

Are there rare familial forms of Gestational trophoblastic disease?

While sporadic cases are the norm, there is a very rare condition known as Recurrent Hydatidiform Mole (RHM), which can have an underlying genetic cause. In these rare instances, families may carry a mutation in the NLRP7 or KHDC3L genes. These genes are involved in the maternal effect process, which governs how the embryo develops during the earliest stages of pregnancy. If a woman carries mutations in both copies of these genes (autosomal recessive inheritance), she may experience recurrent cases of Gestational trophoblastic disease. This is the only scenario where the condition follows a clear Mendelian inheritance pattern.

How is the risk assessed for future pregnancies?

For most patients, the risk of recurrence after a single episode of Gestational trophoblastic disease remains very low, generally reported as less than 1-2%. However, for those who experience multiple or recurrent molar pregnancies, clinicians may recommend specific evaluations. The following steps are often taken to assess genetic risk:

• Clinical History Review: Evaluating the number and type of previous molar pregnancies.


• Genetic Testing: Targeted sequencing of the NLRP7 and KHDC3L genes may be ordered if there is a history of recurrent, unexplained molar pregnancies.


• Parental Karyotyping: To rule out balanced translocations or other chromosomal variations in the parents that could increase the risk of abnormal fertilization.


• Pathology Review: Expert review of the tissue from the Gestational trophoblastic disease to confirm the diagnosis (e.g., complete vs. partial mole).

What is the role of genetic counseling in this context?

Genetic counseling is highly recommended for any individual or couple who has experienced recurrent Gestational trophoblastic disease. A genetic counselor can help interpret the likelihood of a genetic cause versus a sporadic occurrence. For those with confirmed mutations in the NLRP7 or KHDC3L genes, reproductive options such as preimplantation genetic testing (PGT) or the use of donor eggs may be discussed. Our community at DiseaseMaps.org, which currently includes 406 individuals affected by Gestational trophoblastic disease, often highlights the importance of seeking specialized care at centers that understand the rare familial variants of this condition.

Next steps

• Consult with a reproductive endocrinologist or a gynecologic oncologist to review your specific clinical history.


• Request a referral to a clinical geneticist if you have experienced more than one molar pregnancy.


• Join the Gestational trophoblastic disease community at DiseaseMaps.org to connect with others who have navigated these complex fertility challenges.


• Keep detailed records of all pathology reports from your pregnancies to share with your medical team.

Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases Information Center (GARD): Gestational Trophoblastic Disease.


• Orphanet: Recurrent hydatidiform mole.


• OMIM (Online Mendelian Inheritance in Man): Hydatidiform mole, recurrent, 1 (NLRP7).


• American College of Obstetricians and Gynecologists (ACOG): Practice Bulletin on Gestational Trophoblastic Disease.